Scientex Berhad Inkomsten in het verleden
Verleden criteriumcontroles 5/6
Scientex Berhad has been growing earnings at an average annual rate of 6.5%, while the Chemicals industry saw earnings growing at 6.5% annually. Revenues have been growing at an average rate of 5.8% per year. Scientex Berhad's return on equity is 14.2%, and it has net margins of 12.2%.
Belangrijke informatie
6.5%
Groei van de winst
6.3%
Groei van de winst per aandeel
| Chemicals Groei van de industrie | 8.9% |
| Inkomstengroei | 5.8% |
| Rendement op eigen vermogen | 14.2% |
| Nettomarge | 12.2% |
| Laatste winstupdate | 31 Jul 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Scientex Berhad (KLSE:SCIENTX) Has Announced A Dividend Of MYR0.06
Sep 30
Analysts Are Updating Their Scientex Berhad (KLSE:SCIENTX) Estimates After Its Annual Results
Sep 26Scientex Berhad (KLSE:SCIENTX) Is Looking To Continue Growing Its Returns On Capital
Sep 09Scientex Berhad (KLSE:SCIENTX) Ticks All The Boxes When It Comes To Earnings Growth
Aug 06Scientex Berhad Just Recorded A 7.4% Revenue Beat: Here's What Analysts Think
Jun 25Scientex Berhad (KLSE:SCIENTX) Is Increasing Its Dividend To MYR0.06
Jun 24Scientex Berhad Just Beat Revenue By 7.4%: Here's What Analysts Think Will Happen Next
Mar 28Here's Why Scientex Berhad (KLSE:SCIENTX) Has Caught The Eye Of Investors
Mar 27An Intrinsic Calculation For Scientex Berhad (KLSE:SCIENTX) Suggests It's 30% Undervalued
Sep 23Scientex Berhad (KLSE:SCIENTX) Will Pay A Dividend Of MYR0.05
Sep 22Scientex Berhad (KLSE:SCIENTX) Is Paying Out A Larger Dividend Than Last Year
Jun 26Estimating The Fair Value Of Scientex Berhad (KLSE:SCIENTX)
May 11Scientex Berhad (KLSE:SCIENTX) May Have Issues Allocating Its Capital
Jan 27Scientex Berhad (KLSE:SCIENTX) Is Paying Out A Dividend Of MYR0.05
Dec 09Scientex Berhad (KLSE:SCIENTX) Has Affirmed Its Dividend Of MYR0.05
Oct 02Scientex Berhad (KLSE:SCIENTX) Shares Could Be 35% Below Their Intrinsic Value Estimate
Sep 23Here's Why Scientex Berhad (KLSE:SCIENTX) Can Manage Its Debt Responsibly
Sep 08Here's What's Concerning About Scientex Berhad's (KLSE:SCIENTX) Returns On Capital
Jul 13Here's Why I Think Scientex Berhad (KLSE:SCIENTX) Is An Interesting Stock
Apr 28Is There An Opportunity With Scientex Berhad's (KLSE:SCIENTX) 46% Undervaluation?
Mar 09These 4 Measures Indicate That Scientex Berhad (KLSE:SCIENTX) Is Using Debt Reasonably Well
Dec 09Calculating The Intrinsic Value Of Scientex Berhad (KLSE:SCIENTX)
Oct 21Return Trends At Scientex Berhad (KLSE:SCIENTX) Aren't Appealing
Sep 24I Built A List Of Growing Companies And Scientex Berhad (KLSE:SCIENTX) Made The Cut
Aug 21Does Scientex Berhad (KLSE:SCIENTX) Have A Healthy Balance Sheet?
Jun 08Is There An Opportunity With Scientex Berhad's (KLSE:SCIENTX) 28% Undervaluation?
May 26Scientex Berhad (KLSE:SCIENTX) Has Some Way To Go To Become A Multi-Bagger
May 11Scientex Berhad (KLSE:SCIENTX) Has A Rock Solid Balance Sheet
Mar 07Scientex Berhad's (KLSE:SCIENTX) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Feb 23Should We Be Excited About The Trends Of Returns At Scientex Berhad (KLSE:SCIENTX)?
Feb 09Are Investors Undervaluing Scientex Berhad (KLSE:SCIENTX) By 25%?
Jan 27
Here's What We Learned About The CEO Pay At Scientex Berhad (KLSE:SCIENTX)
Jan 15Scientex Berhad (KLSE:SCIENTX) Passed Our Checks, And It's About To Pay A RM0.13 Dividend
Dec 30Here's Why We Think Scientex Berhad (KLSE:SCIENTX) Is Well Worth Watching
Dec 29Scientex Berhad (KLSE:SCIENTX) Has Gifted Shareholders With A Fantastic 186% Total Return On Their Investment
Dec 18What Type Of Shareholders Own The Most Number of Scientex Berhad (KLSE:SCIENTX) Shares?
Dec 06Scientex Berhad (KLSE:SCIENTX) Has A Rock Solid Balance Sheet
Nov 24Opbrengsten en kosten
Opbrengsten en kosten
Hoe Scientex Berhad geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 31 Jul 24 | 4,476 | 545 | 0 | 0 |
| 30 Apr 24 | 4,379 | 524 | 288 | 0 |
| 31 Jan 24 | 4,268 | 504 | 288 | 0 |
| 31 Oct 23 | 4,154 | 469 | 288 | 0 |
| 31 Jul 23 | 4,077 | 438 | 288 | 0 |
| 30 Apr 23 | 4,117 | 448 | 286 | 0 |
| 31 Jan 23 | 4,113 | 427 | 286 | 0 |
| 31 Oct 22 | 4,087 | 414 | 286 | 0 |
| 31 Jul 22 | 3,985 | 410 | 286 | 0 |
| 30 Apr 22 | 3,844 | 428 | 258 | 0 |
| 31 Jan 22 | 3,827 | 449 | 258 | 0 |
| 31 Oct 21 | 3,782 | 468 | 258 | 0 |
| 31 Jul 21 | 3,656 | 457 | 258 | 0 |
| 30 Apr 21 | 3,640 | 457 | 236 | 0 |
| 31 Jan 21 | 3,436 | 416 | 236 | 0 |
| 31 Oct 20 | 3,443 | 402 | 236 | 0 |
| 31 Jul 20 | 3,519 | 390 | 236 | 0 |
| 30 Apr 20 | 3,503 | 381 | 213 | 0 |
| 31 Jan 20 | 3,559 | 385 | 213 | 0 |
| 31 Oct 19 | 3,411 | 361 | 213 | 0 |
| 31 Jul 19 | 3,247 | 334 | 213 | 0 |
| 30 Apr 19 | 3,029 | 283 | 167 | 0 |
| 31 Jan 19 | 2,797 | 272 | 167 | 0 |
| 31 Oct 18 | 2,661 | 266 | 167 | 0 |
| 31 Jul 18 | 2,603 | 285 | 167 | 0 |
| 30 Apr 18 | 2,528 | 274 | 164 | 0 |
| 31 Jan 18 | 2,568 | 279 | 164 | 0 |
| 31 Oct 17 | 2,523 | 276 | 164 | 0 |
| 31 Jul 17 | 2,403 | 256 | 164 | 0 |
| 30 Apr 17 | 2,318 | 238 | 163 | 0 |
| 31 Jan 17 | 2,226 | 233 | 163 | 0 |
| 31 Oct 16 | 2,185 | 232 | 163 | 0 |
| 31 Jul 16 | 2,201 | 241 | 163 | 0 |
| 30 Apr 16 | 2,092 | 236 | 122 | 0 |
| 31 Jan 16 | 2,004 | 217 | 122 | 0 |
| 31 Oct 15 | 1,921 | 189 | 122 | 0 |
| 31 Jul 15 | 1,802 | 158 | 122 | 0 |
| 30 Apr 15 | 1,765 | 158 | 112 | 0 |
| 31 Jan 15 | 1,736 | 152 | 112 | 0 |
| 31 Oct 14 | 1,657 | 149 | 112 | 0 |
| 31 Jul 14 | 1,590 | 148 | 112 | 0 |
| 30 Apr 14 | 1,546 | 130 | 96 | 0 |
| 31 Jan 14 | 1,465 | 123 | 96 | 0 |
Kwaliteitswinsten: SCIENTX has high quality earnings.
Groeiende winstmarge: SCIENTX's current net profit margins (12.2%) are higher than last year (10.7%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: SCIENTX's earnings have grown by 6.5% per year over the past 5 years.
Versnelling van de groei: SCIENTX's earnings growth over the past year (24.4%) exceeds its 5-year average (6.5% per year).
Winst versus industrie: SCIENTX earnings growth over the past year (24.4%) exceeded the Chemicals industry 24.4%.
Rendement op eigen vermogen
Hoge ROE: SCIENTX's Return on Equity (14.2%) is considered low.